IRIS
KLAIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.313
EU - Europa 3.504
NA - Nord America 3.274
SA - Sud America 633
AF - Africa 128
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 11.862
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.096
SG - Singapore 2.404
RU - Federazione Russa 1.740
CN - Cina 951
IT - Italia 641
BR - Brasile 521
HK - Hong Kong 406
VN - Vietnam 254
DE - Germania 225
UA - Ucraina 171
FI - Finlandia 155
NL - Olanda 122
GB - Regno Unito 110
IE - Irlanda 110
CA - Canada 106
IN - India 91
AR - Argentina 47
CI - Costa d'Avorio 46
MX - Messico 43
SE - Svezia 43
FR - Francia 41
ZA - Sudafrica 36
KR - Corea 32
PL - Polonia 32
BD - Bangladesh 26
AT - Austria 25
ID - Indonesia 19
ES - Italia 17
IQ - Iraq 17
TR - Turchia 16
UZ - Uzbekistan 15
BE - Belgio 14
EC - Ecuador 14
BG - Bulgaria 13
PY - Paraguay 11
CL - Cile 9
AE - Emirati Arabi Uniti 8
CO - Colombia 8
IR - Iran 8
JP - Giappone 8
MA - Marocco 8
PE - Perù 8
PK - Pakistan 8
IL - Israele 7
EG - Egitto 6
JO - Giordania 6
MY - Malesia 6
TT - Trinidad e Tobago 6
AL - Albania 5
CH - Svizzera 5
KE - Kenya 5
RO - Romania 5
SA - Arabia Saudita 5
TN - Tunisia 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
EU - Europa 4
GY - Guiana 4
LT - Lituania 4
PA - Panama 4
PT - Portogallo 4
UY - Uruguay 4
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
BY - Bielorussia 3
DK - Danimarca 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
SI - Slovenia 3
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
DJ - Gibuti 2
DM - Dominica 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GR - Grecia 2
GT - Guatemala 2
HT - Haiti 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RW - Ruanda 2
SN - Senegal 2
TH - Thailandia 2
TZ - Tanzania 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
CD - Congo 1
DZ - Algeria 1
EE - Estonia 1
GH - Ghana 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
Totale 11.844
Salva come PNG Salva come JPEG
Città #
Singapore 1.055
Moscow 425
Hong Kong 404
Ashburn 328
Beijing 279
Chandler 254
Santa Clara 230
Hefei 184
Millbury 145
Naples 145
Jacksonville 111
Los Angeles 110
Amsterdam 109
Princeton 104
Boston 90
Ho Chi Minh City 88
Nanjing 79
Napoli 66
Buffalo 65
Hanoi 54
Redondo Beach 53
São Paulo 53
Munich 51
Ottawa 50
Woodbridge 49
New York 48
Wilmington 47
The Dalles 36
Des Moines 35
Houston 35
Kochi 35
Lawrence 34
Seoul 32
Dallas 31
Helsinki 25
Nanchang 25
Seattle 25
Frankfurt am Main 24
Dublin 23
Warsaw 23
London 21
Rio de Janeiro 21
Dong Ket 20
Hebei 20
Nuremberg 20
Tianjin 20
San Giovanni Rotondo 19
Washington 19
Jiaxing 18
Mexico City 18
Milan 18
Toronto 18
Brooklyn 17
Johannesburg 17
Turku 16
Chennai 15
Lappeenranta 15
Montreal 15
Orem 15
Denver 14
Falls Church 14
Norwalk 14
Rome 13
Changsha 12
Haiphong 12
Shenyang 12
Sofia 12
Stockholm 12
Chicago 11
San Francisco 11
Tashkent 11
Vienna 11
Atlanta 10
Baghdad 10
Curitiba 10
Brasília 9
Porto Alegre 9
San Mateo 9
Courcelles 8
Falkenstein 8
Guangzhou 8
Kunming 8
Ninh Bình 8
Poplar 8
Salerno 8
Belo Horizonte 7
Biên Hòa 7
Centro 7
Da Nang 7
Dhaka 7
New Delhi 7
Phoenix 7
San Jose 7
Thái Bình 7
Tokyo 7
Amman 6
Ardabil 6
Boardman 6
Changchun 6
Düsseldorf 6
Totale 5.773
Salva come PNG Salva come JPEG
Nome #
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 133
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 132
La scintigrafia con 131I metaiodobenzilguanidina in pazienti con sospetto feocromocitoma: confronto con TC e parametri bioumorali 127
Added prognostic value of left ventricular shape by gated SPECT imaging in patients with suspected coronary artery disease and normal myocardial perfusion 125
Comparison between computed tomography multislice and high-field magnetic resonance in the diagnostic evaluation of patients with renal masses 124
Quantification of Coronary Artery Atherosclerotic Burden and Muscle Mass: Exploratory Comparison of Two Freely Available Software Programs 124
Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in the identification of obstructive coronary artery disease 123
Assessment of acute myocarditis by cardiac magnetic resonance imaging: Comparison of qualitative and quantitative analysis methods 121
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge 121
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis 117
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 116
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 115
The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results 115
Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer 115
Prediction of 2-[18F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study 114
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 112
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives 111
Advances in functional imaging of differentiated thyroid cancer 111
Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via 18F-Sodium Fluoride PET/CT Imaging 109
Insights into Myocardial Perfusion PET Imaging: the Coronary Flow Capacity 109
Impairment of bone status in patients with central diabetes insipidus 109
Minimally invasive percutaneous treatment for osteoid osteoma of the Spine. A case report 108
Whole-body radioiodine effective half-life in patients with differentiated thyroid cancer 107
La scintigrafia surrenalica con indio-111 octreotide in un caso di feocromocitoma maligno: confronto tra tecnica planare e tomografica (SPECT) 106
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer 106
Valutazione morfo-funzionale del rene nella fibrosi retroperitoneale: correlazioni tra tomografia computerizzata, risonanza magnetica e scintigrafia renale dinamica 104
Comparison of simultaneous 18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer 104
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment 103
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 100
Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT) 100
The diagnostic role of total-body 18F-FDG PET/CT in patients with multiple tumors: a report of the association of thyroid cancer with lung or renal tumors 100
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 98
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 98
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. 97
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 97
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study 96
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose. 96
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 96
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 95
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 95
Characterization with hybrid imaging of cystic pheochromocytomas: Correlation with pathology 94
Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report 94
Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus 93
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases. 93
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 93
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis 92
Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives 90
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer 90
Subclinical hyperthyroidism: clinical features and treatment options. 88
Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the OpenDose Project 88
Hyperfunctioning parathyroid gland and skeletal involvement on [18F]fluorocholine PET/CT: one look with two views 87
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma 87
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis 86
Cardovascular safety of acute recombinant human thyrotropin administration in patients monitored for differentiated thyroid cancer. 86
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study 86
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients 86
Incremental value of sestamibi SPECT/CT over dual-phase planar scintigraphy in patients with primary hyperparathyroidism and inconclusive ultrasound 86
Cardiac hybrid imaging: novel tracers for novel targets 86
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 85
A case of an elderly patient with advanced disease and non-radioiodine-avid metastases 85
Qualitative heterogeneous signal drop on chemical shift (Cs) mr imaging: Correlative quantitative analysis between cs signal intensity index and contrast washout parameters using t1-weighted sequences 84
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience 82
Diagnostica integrata del feocromocitoma 82
“Ruolo della PET (tomografia ad emissione di positroni) con 2-(18F)Fluoro-2-Desossiglucosio (FDG) nel carcinoma differenziato della tiroide” 82
Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study 82
111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma 81
La tomografia a emissione di positroni (PET) con F-18 FDG nello studio delle formazioni espansive a sede surrenalica: confronto tra lesioni benigne e maligne 80
The role of radiolabeled somatostatin analogs in adrenal imaging. 79
131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters 77
Tetrofosmin thyroid scintigraphy 77
Preclinical imaging for the study of mouse models of thyroid cancer 77
Expanding the long‑axial feld‑of‑view PET‑CT horizons: unveiling new arrows in our quiver 76
The role of radiolabeled somatostatin analogs in adrenal imaging. 76
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer. 76
External validation of a predictive model for post-treatment persistent disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer 75
Parathyroid scintigraphy with 99mTc-MIBI in hyperparathyroidism. A comparison between diagnostic imaging technics in the location and characterization of glandular hyperfunction and in the evaluation of skeletal changes 75
Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer 74
Metastatic castration‑resistant prostate cancer therapy: the quest for the perfect molecule 73
Tc-99m MIBI imaging in the initial diagnosis and post-surgery follow-up of patients with thyroid cancer 73
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. 73
Diagnostic evaluation of thyroid involvement by histiocytosis X. 73
L'incidenza della scoliosi in rapporto a disturbi endocrini nell'età evolutiva 73
Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. 72
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors 71
Utilizzo del TSH ricombinante nella diagnostica del carcinoma differenziato della tiroide:trials multicentrici di validazione 71
New opportunities for dosimetric approach in patients with differentiated thyroid cancer 71
Familial pheochromocytoma in Sipple's syndrome. A comparison between scintigraphy with 131I-meta-iodobenzylguanidine, computed tomography and echography 70
Role of the neck ultrasonography, of thyroglobulin after rhTSH and of FDGPET in post surgical follow-up of differentiated thyroid cancer 70
Diagnostic accuracy of radionuclide imaging using iodine-131 nor-cholesterol or MIBG in patients with hypersecreting or non-hypersecreting adrenal tumors. 67
The use of recombinant human TSH in the follow-up of differentiated thyroid thyroid cancer: experience from a large pateint cohort in a single centre. 67
PET/CT in the management of differentiated thyroid cancer 67
Radionuclide imaging of neuroendocrine tumors: a comparative study using radiolabeled MIBG and octreotide. 66
Technetium-99m-tetrofosmin regional myocardial uptake at rest: relation to severity of coronary artery stenosis in previous myocardial infarction 65
Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer 64
Non-Hodgkin's lymphoma in a patient with follicular thyroid cancer: the role of Tc-99m methoxy isobutyl isonitrile imaging 64
Caratterizzazione scintigrafica delle lesioni espansive a sede surrenalica: confronto con l'imaging a risonanza magnetica 64
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma. 64
Detection of pericardial effusion during Tc-99m MIBI parathyroid imaging in a patient with chronic renal failure 63
Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. 63
Il feocromocitoma familiare nella sindrome di Sipple: confronto tra scintigrafia con 131I metaiodobenzilguanidina, tomografia computerizzata ed ecografia 62
Totale 9.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021308 0 0 0 0 0 64 30 40 44 32 66 32
2021/2022837 31 13 33 27 25 15 9 35 108 34 161 346
2022/2023728 141 37 24 30 92 74 7 69 87 107 41 19
2023/2024758 40 89 76 74 52 83 29 66 17 18 136 78
2024/20253.952 210 268 10 12 103 242 448 242 310 425 1.371 311
2025/20264.467 860 575 811 708 1.262 251 0 0 0 0 0 0
Totale 12.089